pubmed-article:9873739 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9873739 | lifeskim:mentions | umls-concept:C0012920 | lld:lifeskim |
pubmed-article:9873739 | lifeskim:mentions | umls-concept:C0027388 | lld:lifeskim |
pubmed-article:9873739 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:9873739 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:9873739 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
pubmed-article:9873739 | pubmed:issue | 23 | lld:pubmed |
pubmed-article:9873739 | pubmed:dateCreated | 1999-1-21 | lld:pubmed |
pubmed-article:9873739 | pubmed:abstractText | Alkannin and shikonin are naturally occurring naphthoquinones. We have tested several derivatives of the title compounds and we have found that naphthoquinones bearing at least one phenolic hydroxyl group are potent inhibitors of topoisomerase I. The ability of the tested compounds to complex Zn++ parallels with a few exceptions their topoisomerase I inhibition properties while their intercalation and redox properties do not. | lld:pubmed |
pubmed-article:9873739 | pubmed:language | eng | lld:pubmed |
pubmed-article:9873739 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873739 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9873739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873739 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9873739 | pubmed:month | Dec | lld:pubmed |
pubmed-article:9873739 | pubmed:issn | 0960-894X | lld:pubmed |
pubmed-article:9873739 | pubmed:author | pubmed-author:LOJJ | lld:pubmed |
pubmed-article:9873739 | pubmed:author | pubmed-author:PapageorgiouV... | lld:pubmed |
pubmed-article:9873739 | pubmed:author | pubmed-author:CouladourosE... | lld:pubmed |
pubmed-article:9873739 | pubmed:author | pubmed-author:PitsinosE NEN | lld:pubmed |
pubmed-article:9873739 | pubmed:author | pubmed-author:PlytaZ FZF | lld:pubmed |
pubmed-article:9873739 | pubmed:author | pubmed-author:MellidisA SAS | lld:pubmed |
pubmed-article:9873739 | pubmed:author | pubmed-author:AssimopoulouA... | lld:pubmed |
pubmed-article:9873739 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9873739 | pubmed:day | 1 | lld:pubmed |
pubmed-article:9873739 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:9873739 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9873739 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9873739 | pubmed:pagination | 3385-90 | lld:pubmed |
pubmed-article:9873739 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:9873739 | pubmed:meshHeading | pubmed-meshheading:9873739-... | lld:pubmed |
pubmed-article:9873739 | pubmed:meshHeading | pubmed-meshheading:9873739-... | lld:pubmed |
pubmed-article:9873739 | pubmed:meshHeading | pubmed-meshheading:9873739-... | lld:pubmed |
pubmed-article:9873739 | pubmed:meshHeading | pubmed-meshheading:9873739-... | lld:pubmed |
pubmed-article:9873739 | pubmed:meshHeading | pubmed-meshheading:9873739-... | lld:pubmed |
pubmed-article:9873739 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9873739 | pubmed:articleTitle | Inhibition of topoisomerase I by naphthoquinone derivatives. | lld:pubmed |
pubmed-article:9873739 | pubmed:affiliation | Chemistry Laboratories, Agricultural University of Athens, Greece. | lld:pubmed |
pubmed-article:9873739 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9873739 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:9873739 | lld:chembl |